Total investment volume $363 million
________________________________

Neuralink is developing an interface for direct control of computers and related machines using the power of thought. The company was founded by Elon Musk and has already developed the first implantable neurointerface chips, which are being tested on animals.

Neuralink is positioned as a breakthrough technology that will facilitate the management of complex machines and also become a tool for treating disorders of the musculoskeletal and nervous systems.

The risks for developers of neurointerfaces include the inability to connect sensors to individual neurons at the current stage of electronics miniaturization. In addition, the FDA has not yet given permission to test the Neuralink chip on humans due to the high risk during installation and removal of the chip. At the same time, the potential for development is enormous and essentially represents a new stage of human evolution as a species capable of integrating with machines.
______________________________________

Number of employees: 250-500
______________________________________

Headquarters location: Fremont, California, USA